FindMyKOL

Noah Kolb, MD

Enriched profile

Professor, Neurological Sciences · University of Vermont

ORCID↗NPI↗
✓ Itemized profile
Region🇺🇸 Burlington, VT · Northeast · United StatesSpecialtyNeurologyFocusPeripheral Neuropathies and Disorders+4
Active KOLFindMyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2024NIH funding2021–2026

Noah Kolb is Professor, Neurological Sciences at University of Vermont. OpenAlex indexes 61 publications with 2,201 citations (h-index 23); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.

Data verified 3 Nov 2026

Overview

Updated 3 Nov 2026

Noah Kolb, M.D., is Professor, Neurological Sciences at University of Vermont. The public record shows 61 publications with 2,201 citations (h-index 23), centered on Peripheral Neuropathies and Disorders, Cancer Treatment and Pharmacology, Hereditary Neurological Disorders. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 3 companies, 1 NIH-funded awards (2021–2026).

  • Top research focus: Peripheral Neuropathies and Disorders
  • 3 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 3 companies

Generated from the cited public record · current as of 3 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Pain1 trialNeuralgia1 trialMultiple SclerosisCOVID-19Myasthenia GravisCIDP / Inflammatory Neuropathy

Research focus

OpenAlex concept fingerprint
Peripheral Neuropathies and DisordersCancer Treatment and PharmacologyHereditary Neurological DisordersPeripheral Nerve DisordersCancer survivorship and care

Drugs & molecules

across trials, industry payments and publications
Vyvgartgeneric · Efgartigimod alfaClinical trials—Industry payments15Publications—Vyvgart Hytrulogeneric · Efgartigimod alfa / hyaluronidaseClinical trials—Industry payments11Publications—Firdapsegeneric · AmifampridineClinical trials—Industry payments1Publications—Zilbrysqgeneric · ZilucoplanClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Argenx Us, Inc.Clinical trials—Industry payments26Catalyst Pharmaceuticals, Inc.Clinical trials—Industry payments1Disarm TherapeuticsClinical trials1Industry payments—UCB, Inc.Clinical trials—Industry payments1University of RochesterClinical trials1Industry payments—University of VermontClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
61publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

2,201citations

Citations across these publications.

23h-index

H-index from these publications. i10-index 30.

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials ↓
3companies · 2021–2024

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2021–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 3 Nov 2026

Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 3 Nov 2026

3 companies reported payments to CMS in program years 2021–2024. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    71%
    Gabapentinoids32.3%
    Gabapentin81%Pregabalin19%
    Part D<11 patients
    SNRI17.3%
    Duloxetine Hcl100%
    Part D≥18 patients

    + 3 more classes in this area

  • Metabolism & gastrointestinal

    10.7%
    Corticosteroid10.7%
    Prednisone100%
    Part D<11 patients
  • Cardiovascular

    9.7%
    Antiarrhythmic9.7%
    Mexiletine Hcl66%Lidocaine34%
    Part D<11 patients
All 5 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)50.3% facility · 49.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 3 Nov 2026

1 NIH research award on record, funded 2021–2026 per NIH RePORTER. The latest:

Congress activity

Updated 3 Nov 2026

1 congress contribution (2018) across ASCO per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Online presence

Updated 3 Nov 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/noah-kolb-md

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Apple Podcasts

    podcasts.apple.com/us/podcast/january-7-2014/id266288159

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗
  • Apple Podcasts

    podcasts.apple.com/us/podcast/october-2026-peripheral-nerve-and-motor-neuron/id1728724856

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗
  • Other

    continuumaudio.libsyn.com/october-2026-peripheral-nerve-and-motor-neuron-disorders-issue-with-dr-noah-kolb

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →continuumaudio.libsyn.com ↗
  • Other

    uvmcommunity.uvm.edu/portal/uvmcc_members

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uvmcommunity.uvm.edu ↗
  • Other

    usnews.com/doctors/noah-kolb-2419133

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →usnews.com ↗
  • Other

    uvm.edu/larnermed/bios/profile/noah-kolb

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uvm.edu ↗
  • Other

    uvmhealth.org/providers/noah-a-kolb-md

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uvmhealth.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 3 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.